TISSUE DONATION IS CRITICAL TO FIND TREATMENTS! Click here to learn more.
Exploring Histotripsy as a Treatment Option for EHE Tuesday, October 14, 2025 4:00 – 5:00 pm ET Dr. Jiping Wang, Surgical Oncologist, Dana-Farber Cancer Institute Dr. Paul Shyn, Department of Radiology, Brigham and Women’s Hospital Dr. Michael Wagner, Medical Oncologist, Dana-Farber Cancer Institute Join us for an educational discussion on histotripsy, an emerging treatment for […]
Read MoreUnderstanding Palliative Care: An Extra Layer of Support in Your Care Journey Tuesday, September 23, 2025 6:00 – 7:00 pm ET Elizabeth Loggers, MD, PhD Medical Director, Supportive and Palliative Care Fred Hutchinson Cancer Center Join us for an enlightening webinar with Dr. Elizabeth Loggers, Medical Director of Supportive and Palliative Care at the Fred […]
Read MoreDr. Scott M. Schuetze, University of Michigan, Rogel Cancer Center, will provide an overview of the rationale for treatment of EHE with trametinib, an oral inhibitor of the MEK kinase; the trial design of 10015/SARC033; and the results of the primary and secondary study endpoints. The presentation will also include an update on exploratory investigation […]
Read MoreJoin us for EHE 360 Connect on Wednesday, January 22, 2025, 12:00-1:00 pm ET. This webinar features Dr. Silvia Stacchiotti, Medical Oncologist at the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, presenting “Sirolimus for the Treatment of EHE.” In this session, Dr. Stacchiotti will highlight data currently available on the use of Sirolimus to […]
Read MoreJoin us for EHE 360 Connect on Wednesday, July 24, 2024, 5-6 pm ET. This webinar features Greg Cote, MD, PhD, medical oncologist, and early-stage clinical trialist from Mass General Cancer Center presenting “Clinical Trials for EHE.” In this session, Dr. Cote will provide an in-depth look at the drug development process and discuss the […]
Read More